The FDA has approved AbbVie’s elagolix (Orilissa) product, a drug specifically developed for women with moderate to severe endometriosis pain.
FDA Approves Endometriosis Pain Management Treatment
Orginally Published At: Pain Management – Pharmacy Times
Musculoskeletal pain affects a vast majority of the population at some stage during the lifespan.4 After an initial painful musculoskeletal event, such as whiplash or an acute back sprain, recurrent episodes of pain separated by pain-free periods are common.11,18,31 Although, the mechanisms for pain recurrence are unclear unresolved tissue pathology is not considered a driving […]
One of my readers wrote to me in the grips of justifiable outrage about a string of egregiously incompetent healthcare professionals he’d encountered while trying to recover from an injury. It was all routine nonsense from my perspective — I hear a lot of stories like this — but he was in a state of […]
Treatment with the capsaicin 8% patch Qutenza may be more effective than pregabalin for reducing the intensity and area of dynamic mechanical allodynia and for complete resolution of the disorder.
Capsaicin Patch Superior to Pregabalin for Alleviating, Resolving Dynamic Mechanical Allodynia
Orginally Published At: Neuropathic Pain